APA

Xu W., Meng K., Kusano J., Matsuda H., Hara Y., Fujii Y., Suzuki S., Ando E., Wang X., Tu Y., Tanaka S., Sugiyama K., Yamada H. & Hirano T. (20180404). Immunosuppressive efficacy of tetrandrine combined with methylprednisolone against mitogen-activated peripheral blood mononuclear cells of haemodialysis patients. : Clinical and experimental pharmacology & physiology.

Chicago

Xu Wencheng, Meng Kehan, Kusano Junichi, Matsuda Hiroto, Hara Yoshikazu, Fujii Yoshiaki, Suzuki Shinya, Ando Eiki, Wang Xiaoqin, Tu Yuanchao, Tanaka Sachiko, Sugiyama Kentaro, Yamada Haruki and Hirano Toshihiko. 20180404. Immunosuppressive efficacy of tetrandrine combined with methylprednisolone against mitogen-activated peripheral blood mononuclear cells of haemodialysis patients. : Clinical and experimental pharmacology & physiology.

Harvard

Xu W., Meng K., Kusano J., Matsuda H., Hara Y., Fujii Y., Suzuki S., Ando E., Wang X., Tu Y., Tanaka S., Sugiyama K., Yamada H. and Hirano T. (20180404). Immunosuppressive efficacy of tetrandrine combined with methylprednisolone against mitogen-activated peripheral blood mononuclear cells of haemodialysis patients. : Clinical and experimental pharmacology & physiology.

MLA

Xu Wencheng, Meng Kehan, Kusano Junichi, Matsuda Hiroto, Hara Yoshikazu, Fujii Yoshiaki, Suzuki Shinya, Ando Eiki, Wang Xiaoqin, Tu Yuanchao, Tanaka Sachiko, Sugiyama Kentaro, Yamada Haruki and Hirano Toshihiko. Immunosuppressive efficacy of tetrandrine combined with methylprednisolone against mitogen-activated peripheral blood mononuclear cells of haemodialysis patients. : Clinical and experimental pharmacology & physiology. 20180404.